Hereditary Cancer Testing Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the hereditary cancer testing market size evolved in recent years?
The size of the hereditary cancer testing market has expanded significantly in the past few years. The market, which was worth $4.32 billion in 2024, is projected to increase to $4.78 billion in 2025, accruing a compound annual growth rate (CAGR) of 10.8%. This drastic growth during the historical period is due to various factors including an increase in hereditary cancer cases, the implementation of genetic counseling programs, governmental interventions towards cancer prevention, enhanced insurance coverage, a deeper comprehension of gene-environment interactions, as well as the role of patient advocacy and support groups.
What are the predictions for the hereditary cancer testing market size in the coming years?
Expected to witness swift expansion in the coming years, the hereditary cancer testing market is projected to reach a size of $7.37 billion by 2029, with an impressive compound annual growth rate (CAGR) of 11.4%. The predicted growth over this period is due to a variety of factors such as the development of targeted therapies, breakthroughs in precision medicine, an increase in direct-to-consumer testing, international health initiatives, and improvements in bioinformatics. The forecast period also showcases certain trends including progress in genetic sequencing technologies, the rise of telemedicine and remote genetic counseling, precision medicine and individualized treatment, cancer risk assessment models, and ethical and legal aspects.
Get your hereditary cancer testing market report here!
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
What key factors are fueling the growth of the hereditary cancer testing market?
The hereditary cancer testing market is likely to be fueled by the escalating instances of inherited cancer. Genetic mutations, passed down from one generation to another, are the root cause of hereditary cancer syndromes. With the aid of hereditary cancer testing, these specific, transferable, disease-related gene mutations can be identified, thus enabling a thorough cancer risk evaluation for patients. For example, a BioMed Central article on inherited cancer in medical practice from June 2022 reported that approximately 10% of pancreatic cancer instances can be traced back to genetic factors. As such, the surge in hereditary cancer cases propels the expansion of the hereditary cancer testing market.
How is the global hereditary cancer testing market divided into key segments?
The hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-Site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
Who are the key firms paving the way for growth in the hereditary cancer testing market?
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Which trends are expected to transform the hereditary cancer testing market?
The surge in technological innovation is a significant trend growing in prominence within the hereditary cancer testing market. Market leaders are zeroing in on this technological innovation trend to maintain their place in the market. As an example, in March 2022, Myriad Genetics, an American company specializing in genetic testing and precision medicine, revealed a genetic testing that includes a Polygenic Breast Cancer Risk Assessment Score that covers all ancestries. The MyRisk Hereditary Cancer test in tandem with RiskScore provides a customized breast cancer risk evaluation to all women who have never been diagnosed with breast cancer, without considering their ethnic background.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8121
What regions are contributing significantly to the growth of the hereditary cancer testing market?
North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Analytical Standards Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/analytical-standards-global-market-report
Healthcare Analytical Testing Services Global Market Report 2024
Analytical Laboratory Instrument Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
